Fungal infections can be very serious, and they can come out of nowhere. The first case of a Candida auris infection, for example, was documented in 2009, and now, Candida auris infections happen all ...

Just as the Centers for Disease Control and Prevention (CDC) warns about the alarming spread of an emerging drug-resistant fungus, GSK has moved to snatch an FDA-approved drug that could tackle the ...

Fungal infections represent a significant global health challenge, particularly in immunocompromised populations, with annual mortality rates rivalling those of tuberculosis and HIV. Current ...

TRENTON, N.J. (AP) — Merck & Co. said Wednesday that the Food and Drug Administration is reviewing its application to sell a pill form of its drug for preventing dangerous fungal infections in ...

Antifungal chemotherapy relies on exploiting fundamental differences between fungal pathogens and their human hosts. The principal drug classes include azoles, which inhibit the cytochrome P450 enzyme ...

Sept 12 (Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop ...

In a recent study published in npj Antimicrobials and Resistance, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal ...

Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...